Viewing Study NCT03951961


Ignite Creation Date: 2025-12-24 @ 12:18 PM
Ignite Modification Date: 2026-06-06 @ 9:09 PM
Study NCT ID: NCT03951961
Status: TERMINATED
Last Update Posted: 2022-01-21
First Post: 2019-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Sponsor: University of Jena
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module